Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Johnstone, GB

Alan J. Johnstone, Aberdeen GB

Patent application numberDescriptionPublished
20090112211Method of bone surgery - A method of bone surgery including drilling a first bore in a near cortex of the bone with a first drill bit. Then a second drill bit is passed though the first bore towards a far cortex of the bone, the second drill bit comprising a distal shaft portion and a proximal shaft portion, the distal shaft portion having a diameter less than a diameter of the proximal shaft portion such that a shoulder is defined between the distal and proximal shaft portions. Then a second bore is drilled in the far cortex of the bone with the distal shaft portion of the second drill bit whilst the second drill bit is received in the first bore.04-30-2009

Alan John Johnstone, Aberdeen GB

Patent application numberDescriptionPublished
20090012561Tissue Anchor - The invention provides a tissue anchor comprising a first portion and a second portion. At least one point is provided on the first portion and a resilient device is provided between the first and second portions. The one or more points on the first portion can be sharpened and capable of penetrating dense tissue. The resilient device biases the first and second portions apart from one another in order to urge them into a second open configuration. The first and second portions are movable to a closed delivery configuration. The first and second portions are urged towards one another against the bias of the resilient device in the closed delivery configuration.01-08-2009
20120041454TISSUE ANCHOR INSERTION SYSTEM - A tissue anchor insertion system for inserting a tissue anchor into a body tissue such as bone, comprising a cutting device having a sharp leading end to create an aperture in the bone for insertion of the tissue anchor therein. The cutting device is deployed through a sleeve which is a close fit with the cutting device. The distal end of the sleeve is typically configured to penetrate the tissue in which the tissue anchor is to be inserted. A tissue anchor is also deployed through the sleeve, after the sleeve is in position, on a delivery device configured to support the tissue anchor during its insertion into the tissue. Typically the leading end of the sleeve is embedded within the tissue when the tissue anchor emerges from the distal end during the insertion process, so the tissue anchor is not damaged by insertion through the tissue.02-16-2012

Patent applications by Alan John Johnstone, Aberdeen GB

Allana Johnstone, Kippendavie Meadows GB

Patent application numberDescriptionPublished
20080319536Method for introducing an internal helical formation into a flexible tubular material - There is disclosed a method for introducing a helical formation (12-25-2008

Andrew Scott Johnstone, Midlothian GB

Patent application numberDescriptionPublished
20120094384USE OF COMPOUNDS FOR DIFFERENTIATION OF CELLS - The present invention provides a method for differentiating an undifferentiated cell, said method comprising contacting an undifferentiated cell with certain compounds of Formula (I) or a salt thereof.04-19-2012

Andrew Scott Johnstone, Edinburgh Lothian GB

Patent application numberDescriptionPublished
20100267132IN VITRO PRESERVATION OF LIVING ANIMAL CELLS AND COMPOUNDS SUITABLE FOR USE IN THE PRESERVATION OF LIVING ANIMAL CELLS - The invention is directed to compounds of Formula (I)10-21-2010

Cameron Johnstone, Donblane GB

Patent application numberDescriptionPublished
20080226450Turbine with Coaxial Sets of Blades - A turbine (09-18-2008

Clive Johnstone, Appleton GB

Patent application numberDescriptionPublished
20100126504WEARABLE PROTECTIVE DEVICE - A wearable protective device (05-27-2010
20120024289HEADGEAR-MOUNTABLE RESPIRATOR - A headgear-mountable respirator (02-02-2012

Craig Johnstone, Macclesfield GB

Patent application numberDescriptionPublished
20100029754THIOPHENE-CARBOXAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE ENZYME IKK-2 - The invention relates to thiophene carboxamides of formula (I),02-04-2010
20100137397Chemical Compounds - A compound of the formula (1) or a pharmaceutically-acceptable salt: possess glycogen phosphorylase inhibitory activity and accordingly have value in the treatment of disease states associated with increased glycogen phosphorylase activity such as 2 diabetes. Processes for the manufacture of compounds and pharmaceutical compositions containing them are described.06-03-2010
20100216791PYRIDINYLQUINAZOLINAMINE DERIVATIVES AND THEIR USE AS B-RAF INHIBITORS - The invention relates to chemical compounds of the formula (I) or pharmaceutically acceptable salts thereof, which possess B-Raf inhibitory activity and are accordingly useful for their anti cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments of use in the production of an anti-cancer effect in a warm blooded animal such as man.08-26-2010
20110034432BENZAMIDE DERIVATIVES AND THEIR USE AS GLUCOKINASE ACTIVATING AGENTS - Compounds of Formula (I):02-10-2011
20110152234Novel Compounds - The invention relates to thiophene carboxamides of formula (I), wherein A, R06-23-2011

Patent applications by Craig Johnstone, Macclesfield GB

Donna Johnstone, Macclesfield GB

Patent application numberDescriptionPublished
20100035896Combination of N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyri- dine-3-sulphonamide and an anti-mitotic cytotoxic agent - A combination, comprising N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and an anti-mitotic cytotoxic agent.02-11-2010

Justin Johnstone, Wiltshire GB

Patent application numberDescriptionPublished
20100159990CELLULAR BASESTATION - A basestation, for a cellular communication network, is described. The basestation is adapted to store a list of user equipments that are authorized to access the network by means of the basestation. In the event that the basestation receives a location update request from an unauthorized user equipment, the basestation is adapted to send a reject message to the unauthorized user equipment. The reject message specifically identifies the basestation, such that the unauthorized user equipment does not attempt to send any further location update request to the basestation.06-24-2010

Justin Johnstone, Swindon GB

Patent application numberDescriptionPublished
20080305835Cellular basestation - A method of managing registration requests from unauthorized user equipments in a cellular communications network includes monitoring such further registration requests and maintaining a count of the total number of registration requests from said user equipment. Based on the counted number of unsuccessful registration requests, different mechanisms can be used to reject the registration request.12-11-2008

Justin Gordon Johnstone, Somerset GB

Patent application numberDescriptionPublished
20110039564LOAD BALANCING IN A MOBILE COMMUNICATION NETWORK - A cellular access point, amongst a plurality of interconnected cellular access points receives from a first user equipment a connection attempt that would cause the access point to exceed a first predetermined capacity threshold. The cellular access point selects one of the previously connected user equipments and an associated one of the plurality of interconnected cellular access points. The cellular access point initiates a handover of the selected one of the previously connected user equipments to the associated one of the plurality of interconnected cellular access points and establishes a connection with the first user equipment.02-17-2011

Ken Johnstone, London GB

Patent application numberDescriptionPublished
20120129572MOBILE COMMUNICATION DEVICE - A mobile communication device, a mobile communication method and an application manager are provided that can coordinate integration of the functionality of a new application relating to a communication service such a social networking communication service into pre-installed user interface application on the communication device. A mobile communication device is also provided that can update image data such as an avatar relating to a contact in a contact list based on the image data provided by a communication service. A mobile communication device is also provided that can determine whether the device is in a particular network and determine whether the device can access data relating to a service depending on whether the network is in a predetermined category.05-24-2012

Stephen Johnstone, Abingdon GB

Patent application numberDescriptionPublished
20110160135SUPPRESSION OF NEUROENDOCRINE DISEASES - The present invention relates to a method for suppressing neuroendocrine disease. The therapy employs use of a non-cytotoxic protease, which is targeted to a neuroendocrine tumour cell, preferably via a somatostatin or cortistatin receptor, a GHRH receptor, a ghrelin receptor, a bombesin receptor, a urotensin receptor a melanin-concentrating hormone receptor 1; a KiSS-1 receptor or a prolactin-releasing peptide receptor. When so delivered, the protease is internalised and inhibits secretion from said tumour cell. The present invention also relates to polypeptides and nucleic acids for use in said methods.06-30-2011

Stephen Johnstone, Oxfordshire GB

Patent application numberDescriptionPublished
20110171191SUPPRESSION OF NEUROENDOCRINE DISEASES - The present invention relates to a method for suppressing neuroendocrine disease. The therapy employs use of a non-cytotoxic protease, which is targeted to a neuroendocrine tumour cell, preferably via a somatostatin or cortistatin receptor, a GHRH receptor, a ghrelin receptor, a bombesin receptor, a urotensin receptora melanin-concentrating hormone receptor 1; a KiSS-1 receptor or a prolactin-releasing peptide receptor. When so delivered, the protease is internalised and inhibits secretion—from said tumourcell. The present invention also relates to polypeptides and nucleic acids for use in said methods.07-14-2011

William Allan Johnstone, Wiltshire GB

Patent application numberDescriptionPublished
20080223670Cylinder mechanism - A cylinder mechanism includes a housing, a piston slidably held in the housing for defining a fluid chamber for introducing a working fluid thereinto, and a plurality of disc springs for urging the piston toward the fluid chamber. At least two of the disc springs have respective bottom ends facing each other. A ring has an arcuate surface held against respective inner slanted surfaces of the at least two of the disc springs.09-18-2008

William Allan Johnstone, Devizes GB

Patent application numberDescriptionPublished
20120103452PEDAL SIMULATOR - A pedal simulator includes a cylinder mechanism for absorbing a fluid pressure generated in a pressurization chamber of a master cylinder by operating a brake pedal. The cylinder mechanism includes a housing, a piston slidably held in the housing and defining a fluid chamber for introducing a working fluid thereinto, and a plurality of spring members for urging the piston toward the fluid chamber. The housing includes an open end on an opposite side of the housing from the piston, and a lid member which covers the open end. The lid member is composed of a member separate and distinct from the housing. The lid member is provided with a damper made of a rubber member.05-03-2012